Atkinson EN - Search Results

1

The significance of müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms.

Copeland LJ, Silva EG, Gershenson DM, Sneige N, Atkinson EN, Wharton JT. Copeland LJ, et al. Among authors: atkinson en. Obstet Gynecol. 1988 May;71(5):763-70. Obstet Gynecol. 1988. PMID: 2833713

2

Microscopic disease at second-look laparotomy in advanced ovarian cancer.

Copeland LJ, Gershenson DM, Wharton JT, Atkinson EN, Sneige N, Edwards CL, Rutledge FN. Copeland LJ, et al. Among authors: atkinson en. Cancer. 1985 Jan 15;55(2):472-8. doi: 10.1002/1097-0142(19850115)55:2<472::aid-cncr2820550231>3.0.co;2-a. Cancer. 1985. PMID: 3965102

3

Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy.

Gershenson DM, Silva EG, Mitchell MF, Atkinson EN, Wharton JT. Gershenson DM, et al. Among authors: atkinson en. Am J Obstet Gynecol. 1993 Apr;168(4):1178-85; discussion 1185-7. doi: 10.1016/0002-9378(93)90365-p. Am J Obstet Gynecol. 1993. PMID: 8475964

4

Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.

Munkarah AR, Hallum AV 3rd, Morris M, Burke TW, Levenback C, Atkinson EN, Wharton JT, Gershenson DM. Munkarah AR, et al. Among authors: atkinson en. Gynecol Oncol. 1997 Jan;64(1):13-7. doi: 10.1006/gyno.1996.4540. Gynecol Oncol. 1997. PMID: 8995541

5

A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.

Gershenson DM, Morris M, Burke TW, Levenback C, Wolf J, Lee JJ, Thall PF, Atkinson EN, Silva EG, Wharton JT. Gershenson DM, et al. Among authors: atkinson en. Cancer. 1999 Dec 1;86(11):2291-300. Cancer. 1999. PMID: 10590370 Clinical Trial.

6

Grading ovarian serous carcinoma using a two-tier system.

Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG. Malpica A, et al. Among authors: atkinson en. Am J Surg Pathol. 2004 Apr;28(4):496-504. doi: 10.1097/00000478-200404000-00009. Am J Surg Pathol. 2004. PMID: 15087669

7

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: atkinson en. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

8

Prognostic indicators for invasive carcinoma of the vulva.

Rutledge FN, Mitchell MF, Munsell MF, Atkinson EN, Bass S, McGuffee V, Silva E. Rutledge FN, et al. Among authors: atkinson en. Gynecol Oncol. 1991 Sep;42(3):239-44. doi: 10.1016/0090-8258(91)90352-6. Gynecol Oncol. 1991. PMID: 1955186

9

Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration.

Copeland LJ, Hancock KC, Gershenson DM, Stringer CA, Atkinson EN, Edwards CL. Copeland LJ, et al. Among authors: atkinson en. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1095-101. doi: 10.1016/0002-9378(89)90168-3. Am J Obstet Gynecol. 1989. PMID: 2658602

10

Prognosis of surgically determined complete responders in advanced ovarian cancer.

Gershenson DM, Copeland LJ, Wharton JT, Atkinson EN, Sneige N, Edwards CL, Rutledge FN. Gershenson DM, et al. Among authors: atkinson en. Cancer. 1985 Mar 1;55(5):1129-35. doi: 10.1002/1097-0142(19850301)55:5<1129::aid-cncr2820550531>3.0.co;2-o. Cancer. 1985. PMID: 3155643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters